Company Profile
We Develop Novel Bioceutical and Pharmaceutical Products
The company was founded as a bioceutical company that develops products which have pharmacological benefits. As an innovator of proprietary, patented, bioceutical products, Imagenetix focuses on:
- Science driven products and pharmaceutical therapies related to conditions caused by inflammation
- Novel compounds which are patent protected and sold as nutritional supplements
- Imagenetix markets its nutritional products under its own brand, which are based on science and sold primarily in the mass market channel of distribution
- Imagenetix also markets nutritional and OTC pain cream products on a private label basis. Sales of the Company’s private label business is primarily generated internationally
- The Company also has several compounds under drug development for the treatment of inflammatory related diseases
We Believe in Scientific Testing
Imagenetix places heavy emphasis on product development and scientific studies. The Company subjects its proprietary bioceutical products to an array of rigorous and stringently designed scientific tests. Management believes that well designed studies and well executed clinical trials will give superior confidence to clients seeking to market products, consumers purchasing and using products, and companies seeking to enter into licensing agreements.
Scientific testing includes:
- Mechanism of action studies
- Toxicity studies
- Safety studies
- Efficacy studies
Protocols are designed by Imagenetix personnel working in collaboration with an esteemed variety of industry recognized professionals and university scientific staff members. Where appropriate, studies are conducted on a double-blind, placebo-controlled trial basis. Studies are conducted at some of the world’s top laboratory facilities and clinics, universities, and by leading researchers and medical doctors.
By presenting findings at scientific conferences, submitting these landmark studies to peer review journals, and advancing products through clinical studies, Imagenetix is pioneering a new niche for natural-based bioceutical companies and is developing a reputation that will distinguish it from the competition.